(Q45869991)

17 December 2017

title

Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle (English)

1 reference

17 December 2017

Erratum: Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle

corrigendum / erratum

1 reference

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1038/GT.2011.93

author

Seppo Ylä-Herttuala

8

1 reference

17 December 2017

author name string

H Karvinen

1

1 reference

17 December 2017

E Pasanen

2

1 reference

17 December 2017

T T Rissanen

3

1 reference

17 December 2017

P Korpisalo

4

1 reference

17 December 2017

E Vähäkangas

5

1 reference

17 December 2017

A Jazwa

6

1 reference

17 December 2017

M Giacca

7

1 reference

17 December 2017

publication date

12 May 2011

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

18

1 reference

17 December 2017

issue

12

1 reference

17 December 2017

page(s)

1166-1172

1 reference

17 December 2017

Current status of cardiovascular gene therapy

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

New aspects in vascular gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermitt

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-free Survival in Patients With Critical Limb Ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

Adeno-associated virus serotypes: vector toolkit for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

Gene therapy using adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

Treatment of human disease by adeno-associated viral gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

Detection of intact rAAV particles up to 6 years after successful gene transfer in the retina of dogs and primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

High-resolution ultrasound perfusion imaging of therapeutic angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

Recombinant AAV vector encoding human VEGF165 enhances wound healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

In vivo imaging shows abnormal function of vascular endothelial growth factor-induced vasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

Improved survival of ischemic cutaneous and musculocutaneous flaps after vascular endothelial growth factor gene transfer using adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

Inducible adeno-associated virus vectors promote functional angiogenesis in adult organisms via regulated vascular endothelial growth factor expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

Vascular endothelial growth factor-A and platelet-derived growth factor-B combination gene therapy prolongs angiogenic effects via recruitment of interstitial mononuclear cells and paracrine effects rather than improved pericyte coverage of angiogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

Short and long-term effects of hVEGF-A(165) in Cre-activated transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

Nrf2-dependent and -independent responses to nitro-fatty acids in human endothelial cells: identification of heat shock response as the major pathway activated by nitro-oleic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

Imaging of angiogenesis using Cadence contrast pulse sequencing and targeted contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

AAV-mediated VEGF gene transfer into skeletal muscle stimulates angiogenesis and improves blood flow in a rat hindlimb ischemia model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

inferred from DOI database lookup

7 January 2021

based on heuristic

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.66

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GT.2011.66

1 reference

17 December 2017

Dimensions Publication ID

1003966131

0 references

1 reference

17 December 2017